{
    "filename": "pdf.pdf",
    "content_type": "application/pdf",
    "file_size": 59419,
    "metadata": {
        "identifiers": {
            "doi": "10.1016/s0140-6736(20)30317-2",
            "arxiv": null,
            "isbn": null,
            "doc_id": null,
            "url": "http://www.thelancet.com/article/S0140673620303172/pdf"
        },
        "title": "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury",
        "author": "Clark D Russell, Jonathan E Millar, J Kenneth Baillie",
        "date": 2020,
        "affiliations": [
            "University of Alabama Antiviral Drug Discovery and Development Consortium, and is a non-compensated consultant for Gilead Sciences, Regeneron, and SAB Biotherapeutics, which have investigational therapeutics for coronavirus infections. All other authors declare no competing interests.",
            "China National Health Commission. Update on the novel coronavirus pneumonia outbreak (Jan 24, 2020). Beijing: China National Health Commission, 2020. http://www.nhc.gov.cn/xcs/yqfkdt/202001/ c5da49c4c5bf4bcfb320ec2036480627.shtml (accessed Jan 24, 2020)."
        ],
        "journal": "The Lancet",
        "volume": "395",
        "abstract": "We have to be aware of the challenge and concerns brought by 2019-nCoV to our community. Every effort should be given to understand and control the disease, and the time to act is now.",
        "references": "@book{unknown2020a,\n  title = {Update on the novel coronavirus pneumonia outbreak},\n  date = {2020-01-24},\n  url = {http://www.nhc.gov.cn/xcs/yqfkdt/202001/c5da49c4c5bf4bcfb320ec2036480627.shtml},\n  unmatched-authority = {National Health Commission, 2020.},\n  publisher = {China},\n  language = {},\n  address = {Beijing},\n  urldate = {(Jan 24, 2020).},\n  organization = {China National Health Commission}\n}\n@misc{unknown-a,\n  title = {US Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States. Atlanta, GA: US Centers for Disease Control and Prevention, 2020},\n  url = {https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html},\n  language = {},\n  urldate = {(Jan 24, 2020).}\n}\n@incollection{chan-a,\n  author = {Chan, J.F.-W. and Yuan, S. and Kok, K.-H.},\n  title = {A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster},\n  source = {Lancet 2020; published online},\n  date = {Jan},\n  volume = {24},\n  url = {https://doi.org/10.1016/S0140-6736},\n  more-authors = {true},\n  language = {}\n}\n@incollection{huang-a,\n  author = {Huang, C. and Wang, Y. and Li, X.},\n  title = {Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China},\n  source = {Lancet 2020; published online},\n  date = {Jan},\n  volume = {24},\n  url = {https://doi.org/10.1016/S0140-6736},\n  more-authors = {true},\n  language = {}\n}\n@article{leung2004a,\n  author = {Leung, G.M. and Hedley, A.J. and Ho, L.M.},\n  title = {The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients},\n  journal = {Ann Intern Med},\n  date = {2004},\n  volume = {141},\n  pages = {662\u201373},\n  more-authors = {true},\n  language = {}\n}\n@article{assiri2013a,\n  author = {Assiri, A. and Al-Tawfiq, J.A. and Al-Rabeeah, A.A.},\n  title = {and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study},\n  journal = {Lancet Infect Dis},\n  date = {2013},\n  volume = {13},\n  pages = {752\u201361},\n  more-authors = {true},\n  language = {}\n}\n@article{viboud2013a,\n  author = {Viboud, C. and Eisenstein, J. and Reid, A.H. and Janczewski, T.A. and Morens, D.M. and Taubenberger, J.K.},\n  title = {Age- and sex-specific mortality associated with the 1918\u20131919 influenza pandemic in Kentucky},\n  journal = {J Infect Dis},\n  date = {2013},\n  volume = {207},\n  pages = {721\u201329},\n  language = {}\n}\n@incollection{zhong2003a,\n  author = {Zhong, N.S. and Zheng, B.J. and Li, Y.M.},\n  title = {Epidemiology and cause of severe acute respiratory syndrome},\n  booktitle = {(SARS) in Guangdong, People\u2019s Republic of China, in February},\n  date = {2003},\n  volume = {362},\n  pages = {1353\u201358},\n  more-authors = {true},\n  language = {}\n}\n@misc{unknown-b,\n  title = {Announcement from the Headquarter for novel coronavirus pneumonia prevention and control (No. 1). Beijing: China National Health Commission, 2020},\n  url = {http://www.gov.cn/xinwen/2020-01/23/content_5471751.htm},\n  language = {},\n  urldate = {(Jan 23, 2020).}\n}\n@article{stockman2006a,\n  author = {Stockman, L.J. and Bellamy, R. and Garner, P.},\n  title = {SARS: systematic review of treatment effects},\n  journal = {PLoS Med},\n  date = {2006},\n  volume = {3},\n  pages = {343},\n  language = {}\n}\n@article{arabi2018a,\n  author = {Arabi, Y.M. and Mandourah, Y. and Al-Hameed, F.},\n  title = {Corticosteroid therapy for critically ill patients with middle east respiratory syndrome},\n  journal = {Am J Respir Crit Care Med},\n  date = {2018},\n  pages = {757\u201367},\n  more-authors = {true},\n  language = {}\n}\n@incollection{huang-b,\n  author = {Huang, C. and Wang, Y. and Li, X.},\n  title = {Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China},\n  source = {Lancet 2020; published online},\n  date = {Jan},\n  volume = {24},\n  url = {https://doi.org/10.1016/S0140-6736},\n  more-authors = {true},\n  language = {}\n}\n@article{lee2004a,\n  author = {Lee, N. and Allen Chan, K.C. and Hui, D.S.},\n  title = {Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients},\n  journal = {J Clin Virol},\n  date = {2004},\n  volume = {31},\n  pages = {304\u201309},\n  more-authors = {true},\n  language = {}\n}\n@article{lee2004b,\n  author = {Lee, D.T.S. and Wing, Y.K. and Leung, H.C.M.},\n  title = {Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study},\n  journal = {Clin Infect Dis},\n  date = {2004},\n  volume = {39},\n  pages = {1247\u201349},\n  more-authors = {true},\n  language = {}\n}\n@misc{xiao2004a,\n  author = {Xiao, J.Z. and Ma, L. and Gao, J.},\n  title = {Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Nei Ke Za Zhi},\n  date = {2004},\n  volume = {43},\n  pages = {179\u201382},\n  note = {in Chinese},\n  more-authors = {true},\n  language = {}\n}\n@misc{li2004a,\n  author = {Li, Y.M. and Wang, S.X. and Gao, H.S.},\n  title = {Factors of avascular necrosis of femoral head and osteoporosis in SARS patients\u2019 convalescence. Zhonghua Yi Xue Za Zhi},\n  date = {2004},\n  volume = {84},\n  pages = {1348\u201353},\n  note = {in Chinese},\n  more-authors = {true},\n  language = {}\n}\n@article{ni2019a,\n  author = {Ni, Y.-N. and Chen, G. and Sun, J. and Liang, B.-M. and Liang, Z.-A.},\n  title = {The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis},\n  journal = {Crit Care},\n  date = {2019},\n  volume = {23},\n  pages = {99},\n  language = {}\n}\n@article{mcgee2008a,\n  author = {McGee, S. and Hirschmann, J.},\n  title = {Use of corticosteroids in treating infectious diseases},\n  journal = {Arch Intern Med},\n  date = {2008},\n  volume = {168},\n  pages = {1034\u201346},\n  language = {}\n}\n@article{corneli2007a,\n  author = {Corneli, H.M. and Zorc, J.J. and Mahajan, P.},\n  title = {A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis},\n  journal = {N Engl J Med},\n  date = {2007},\n  volume = {357},\n  pages = {331\u201339},\n  more-authors = {true},\n  language = {}\n}\n@article{tang2005a,\n  author = {Tang, N.L.-S. and Chan, P.K.-S. and Wong, C.-K.},\n  title = {Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome},\n  journal = {Clin Chem},\n  date = {2005},\n  volume = {51},\n  pages = {2333\u201340},\n  more-authors = {true},\n  language = {}\n}\n@article{peiris2003a,\n  author = {Peiris, J.S.M. and Chu, C.M. and Cheng, V.C.C.},\n  title = {Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study},\n  journal = {Lancet},\n  date = {2003},\n  volume = {361},\n  pages = {1767\u201372},\n  more-authors = {true},\n  language = {}\n}\n@article{unknown2003a,\n  title = {Project for SARS. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome},\n  journal = {Chin Med J (Engl)},\n  date = {2003},\n  volume = {116},\n  pages = {1283\u201387},\n  language = {},\n  organization = {Beijing Group of National Research}\n}\n@article{arabi2017a,\n  author = {Arabi, Y.M. and Balkhy, H.H. and Hayden, F.G.},\n  title = {Middle East respiratory syndrome},\n  journal = {N Engl J Med},\n  date = {2017},\n  volume = {376},\n  pages = {584\u201394},\n  more-authors = {true},\n  language = {}\n}\n@article{nicholls2003a,\n  author = {Nicholls, J.M. and Poon, L.L.M. and Lee, K.C.},\n  title = {Lung pathology of fatal severe acute respiratory syndrome},\n  journal = {Lancet},\n  date = {2003},\n  volume = {361},\n  pages = {1773\u201378},\n  more-authors = {true},\n  language = {}\n}\n@article{lee2011a,\n  author = {Lee, F.E.-H. and Walsh, E.E. and Falsey, A.R.},\n  title = {The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness},\n  journal = {Chest},\n  date = {2011},\n  volume = {140},\n  pages = {1155\u201361},\n  language = {}\n}\n@incollection{chen-a,\n  author = {Chen, N. and Zhou, M. and Dong, X.},\n  title = {Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study},\n  source = {Lancet 2020; published online},\n  date = {Jan},\n  volume = {30},\n  url = {https://doi.org/10.1016/S0140-6736},\n  more-authors = {true},\n  language = {}\n}\n@article{ashbaugh1967a,\n  author = {Ashbaugh, D.G. and Bigelow, D.B. and Petty, T.L. and Levine, B.E.},\n  title = {Acute respiratory distress in adults},\n  journal = {Lancet},\n  date = {1967},\n  volume = {2},\n  pages = {319\u201323},\n  language = {}\n}\n@article{lewis2019a,\n  author = {Lewis, SR, Pritchard and MW, Thomas and CM, Smith and A.F.},\n  title = {Pharmacological agents for adults with acute respiratory distress syndrome},\n  journal = {Cochrane Database Syst Rev},\n  date = {2019},\n  volume = {7},\n  pages = {004477},\n  language = {}\n}\n@article{venkatesh2018a,\n  author = {Venkatesh, B. and Finfer, S. and Cohen, J.},\n  title = {Adjunctive glucocorticoid therapy in patients with septic shock},\n  journal = {N Engl J Med},\n  date = {2018},\n  volume = {378},\n  pages = {797\u2013808},\n  more-authors = {true},\n  language = {}\n}\n@article{annane2018a,\n  author = {Annane, D. and Renault, A. and Brun-Buisson, C.},\n  title = {Hydrocortisone plus fludrocortisone for adults with septic shock},\n  journal = {N Engl J Med},\n  date = {2018},\n  volume = {378},\n  pages = {809\u201318},\n  more-authors = {true},\n  language = {}\n}\n@article{foug2010a,\n  author = {Foug\u00e8res, E. and Teboul, J.-L. and Richard, C. and Osman, D. and Chemla, D. and Monnet, X.},\n  title = {Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status},\n  journal = {Crit Care Med},\n  date = {2010},\n  volume = {38},\n  pages = {802\u201307},\n  language = {}\n}\n",
        "links": [
            "https://www.who.int/publications-detail/",
            "http://www.who.int/csr/sars/country/table2004_04_21/en/",
            "http://www.thelancet.com",
            "https://www.who.int/internal-publications-detail/",
            "http://www.who.int/emergencies/merscov/en/",
            "https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200122sitrep-2-2019-ncov.pdf",
            "https://www.who.int/csr/don/21january-2020-novel-coronavirus-republic-of-korea-ex-china/en/",
            "https://doi.org/10.1016/",
            "https://www.who.int/csr/don/16-january2020-novel-coronavirus-japan-ex-china/en/",
            "https://www.who.int/csr/don/14-january2020-novel-coronavirus-thailand/en/",
            "https://www.who.int/news-room/detail/23-01-2020-statement-on-themeeting-of-the-international-health-regulations-(2005)-emergencycommittee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov"
        ],
        "emails": [
            "j.k.baillie@ed.ac.uk",
            "cyh-birm@263.net"
        ],
        "pages": "473-475",
        "cited_by": 9,
        "references_ris": "TY  - BOOK\nTI  - Update on the novel coronavirus pneumonia outbreak\nPY  - 2020\nDA  - 2020/01/24\nUR  - http://www.nhc.gov.cn/xcs/yqfkdt/202001/c5da49c4c5bf4bcfb320ec2036480627.shtml\nC1  - National Health Commission, 2020.\nPB  - China\nLA  - \nCY  - Beijing\nC1  - (Jan 24, 2020).\nC1  - China National Health Commission\nER  - \n\nTY  - GEN\nTI  - US Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States. Atlanta, GA: US Centers for Disease Control and Prevention, 2020\nUR  - https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html\nLA  - \nC1  - (Jan 24, 2020).\nER  - \n\nTY  - CHAP\nAU  - Chan, J.F.-W.\nAU  - Yuan, S.\nAU  - Kok, K.-H.\nTI  - A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster\nT2  - Lancet 2020; published online\nPY  - Jan\nDA  - Jan\nVL  - 24\nUR  - https://doi.org/10.1016/S0140-6736\nC1  - true\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Huang, C.\nAU  - Wang, Y.\nAU  - Li, X.\nTI  - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China\nT2  - Lancet 2020; published online\nPY  - Jan\nDA  - Jan\nVL  - 24\nUR  - https://doi.org/10.1016/S0140-6736\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Leung, G.M.\nAU  - Hedley, A.J.\nAU  - Ho, L.M.\nTI  - The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients\nT2  - Ann Intern Med\nPY  - 2004\nDA  - 2004\nVL  - 141\nSP  - 662\nEP  - 73\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Assiri, A.\nAU  - Al-Tawfiq, J.A.\nAU  - Al-Rabeeah, A.A.\nTI  - and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study\nT2  - Lancet Infect Dis\nPY  - 2013\nDA  - 2013\nVL  - 13\nSP  - 752\nEP  - 61\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Viboud, C.\nAU  - Eisenstein, J.\nAU  - Reid, A.H.\nAU  - Janczewski, T.A.\nAU  - Morens, D.M.\nAU  - Taubenberger, J.K.\nTI  - Age- and sex-specific mortality associated with the 1918\u20131919 influenza pandemic in Kentucky\nT2  - J Infect Dis\nPY  - 2013\nDA  - 2013\nVL  - 207\nSP  - 721\nEP  - 29\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Zhong, N.S.\nAU  - Zheng, B.J.\nAU  - Li, Y.M.\nTI  - Epidemiology and cause of severe acute respiratory syndrome\nT2  - (SARS) in Guangdong, People\u2019s Republic of China, in February\nPY  - 2003\nDA  - 2003\nVL  - 362\nSP  - 1353\nEP  - 58\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nTI  - Announcement from the Headquarter for novel coronavirus pneumonia prevention and control (No. 1). Beijing: China National Health Commission, 2020\nUR  - http://www.gov.cn/xinwen/2020-01/23/content_5471751.htm\nLA  - \nC1  - (Jan 23, 2020).\nER  - \n\nTY  - JOUR\nAU  - Stockman, L.J.\nAU  - Bellamy, R.\nAU  - Garner, P.\nTI  - SARS: systematic review of treatment effects\nT2  - PLoS Med\nPY  - 2006\nDA  - 2006\nVL  - 3\nSP  - 343\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Arabi, Y.M.\nAU  - Mandourah, Y.\nAU  - Al-Hameed, F.\nTI  - Corticosteroid therapy for critically ill patients with middle east respiratory syndrome\nT2  - Am J Respir Crit Care Med\nPY  - 2018\nDA  - 2018\nSP  - 757\nEP  - 67\nC1  - true\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Huang, C.\nAU  - Wang, Y.\nAU  - Li, X.\nTI  - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China\nT2  - Lancet 2020; published online\nPY  - Jan\nDA  - Jan\nVL  - 24\nUR  - https://doi.org/10.1016/S0140-6736\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lee, N.\nAU  - Allen Chan, K.C.\nAU  - Hui, D.S.\nTI  - Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients\nT2  - J Clin Virol\nPY  - 2004\nDA  - 2004\nVL  - 31\nSP  - 304\nEP  - 09\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lee, D.T.S.\nAU  - Wing, Y.K.\nAU  - Leung, H.C.M.\nTI  - Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study\nT2  - Clin Infect Dis\nPY  - 2004\nDA  - 2004\nVL  - 39\nSP  - 1247\nEP  - 49\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Xiao, J.Z.\nAU  - Ma, L.\nAU  - Gao, J.\nTI  - Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Nei Ke Za Zhi\nPY  - 2004\nDA  - 2004\nVL  - 43\nSP  - 179\nEP  - 82\nN1  - in Chinese\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Li, Y.M.\nAU  - Wang, S.X.\nAU  - Gao, H.S.\nTI  - Factors of avascular necrosis of femoral head and osteoporosis in SARS patients\u2019 convalescence. Zhonghua Yi Xue Za Zhi\nPY  - 2004\nDA  - 2004\nVL  - 84\nSP  - 1348\nEP  - 53\nN1  - in Chinese\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ni, Y.-N.\nAU  - Chen, G.\nAU  - Sun, J.\nAU  - Liang, B.-M.\nAU  - Liang, Z.-A.\nTI  - The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis\nT2  - Crit Care\nPY  - 2019\nDA  - 2019\nVL  - 23\nSP  - 99\nLA  - \nER  - \n\nTY  - JOUR\nAU  - McGee, S.\nAU  - Hirschmann, J.\nTI  - Use of corticosteroids in treating infectious diseases\nT2  - Arch Intern Med\nPY  - 2008\nDA  - 2008\nVL  - 168\nSP  - 1034\nEP  - 46\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Corneli, H.M.\nAU  - Zorc, J.J.\nAU  - Mahajan, P.\nTI  - A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis\nT2  - N Engl J Med\nPY  - 2007\nDA  - 2007\nVL  - 357\nSP  - 331\nEP  - 39\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Tang, N.L.-S.\nAU  - Chan, P.K.-S.\nAU  - Wong, C.-K.\nTI  - Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome\nT2  - Clin Chem\nPY  - 2005\nDA  - 2005\nVL  - 51\nSP  - 2333\nEP  - 40\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Peiris, J.S.M.\nAU  - Chu, C.M.\nAU  - Cheng, V.C.C.\nTI  - Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study\nT2  - Lancet\nPY  - 2003\nDA  - 2003\nVL  - 361\nSP  - 1767\nEP  - 72\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nTI  - Project for SARS. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome\nT2  - Chin Med J (Engl)\nPY  - 2003\nDA  - 2003\nVL  - 116\nSP  - 1283\nEP  - 87\nLA  - \nC1  - Beijing Group of National Research\nER  - \n\nTY  - JOUR\nAU  - Arabi, Y.M.\nAU  - Balkhy, H.H.\nAU  - Hayden, F.G.\nTI  - Middle East respiratory syndrome\nT2  - N Engl J Med\nPY  - 2017\nDA  - 2017\nVL  - 376\nSP  - 584\nEP  - 94\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Nicholls, J.M.\nAU  - Poon, L.L.M.\nAU  - Lee, K.C.\nTI  - Lung pathology of fatal severe acute respiratory syndrome\nT2  - Lancet\nPY  - 2003\nDA  - 2003\nVL  - 361\nSP  - 1773\nEP  - 78\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lee, F.E.-H.\nAU  - Walsh, E.E.\nAU  - Falsey, A.R.\nTI  - The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness\nT2  - Chest\nPY  - 2011\nDA  - 2011\nVL  - 140\nSP  - 1155\nEP  - 61\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Chen, N.\nAU  - Zhou, M.\nAU  - Dong, X.\nTI  - Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study\nT2  - Lancet 2020; published online\nPY  - Jan\nDA  - Jan\nVL  - 30\nUR  - https://doi.org/10.1016/S0140-6736\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ashbaugh, D.G.\nAU  - Bigelow, D.B.\nAU  - Petty, T.L.\nAU  - Levine, B.E.\nTI  - Acute respiratory distress in adults\nT2  - Lancet\nPY  - 1967\nDA  - 1967\nVL  - 2\nSP  - 319\nEP  - 23\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lewis, SR, Pritchard\nAU  - MW, Thomas\nAU  - CM, Smith\nAU  - A.F.\nTI  - Pharmacological agents for adults with acute respiratory distress syndrome\nT2  - Cochrane Database Syst Rev\nPY  - 2019\nDA  - 2019\nVL  - 7\nSP  - 004477\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Venkatesh, B.\nAU  - Finfer, S.\nAU  - Cohen, J.\nTI  - Adjunctive glucocorticoid therapy in patients with septic shock\nT2  - N Engl J Med\nPY  - 2018\nDA  - 2018\nVL  - 378\nSP  - 797\nEP  - 808\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Annane, D.\nAU  - Renault, A.\nAU  - Brun-Buisson, C.\nTI  - Hydrocortisone plus fludrocortisone for adults with septic shock\nT2  - N Engl J Med\nPY  - 2018\nDA  - 2018\nVL  - 378\nSP  - 809\nEP  - 18\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Foug\u00e8res, E.\nAU  - Teboul, J.-L.\nAU  - Richard, C.\nAU  - Osman, D.\nAU  - Chemla, D.\nAU  - Monnet, X.\nTI  - Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status\nT2  - Crit Care Med\nPY  - 2010\nDA  - 2010\nVL  - 38\nSP  - 802\nEP  - 07\nLA  - \nER  - \n\n",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "introduction": [
            "11 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752\u201361.",
            "13 Viboud C, Eisenstein J, Reid AH, Janczewski TA, Morens DM, Taubenberger JK. Age- and sex-specific mortality associated with the 1918\u20131919 influenza pandemic in Kentucky. J Infect Dis 2013; 207: 721\u201329."
        ]
    },
    "structured_content": {},
    "participants": [
        {
            "participant": "patients",
            "number": 95,
            "context": "SARS-CoV Complication: diabetes7. <mark class=\"stats\">33 (35%) of 95 patients treated with corticosteroid developed corticosteroid-induced diabetes</mark>. SARS-CoV Complication: avascular necrosis in survivors[<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>]"
        },
        {
            "participant": "patients",
            "number": 40,
            "context": "SARS-CoV Complication: avascular necrosis in survivors8. <mark class=\"stats\">Among 40 patients who survived after corticosteroid treatment, 12 (30%) had avascular necrosis and 30 (75%) had osteoporosis</mark>. Influenza Increased mortality[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>]"
        },
        {
            "participant": "studies",
            "number": 10,
            "context": "Influenza Increased mortality9. <mark class=\"stats\">Risk ratio for mortality 1\u00b775 (95% CI 1\u00b73\u20132\u00b74) in a meta-analysis of 6548 patients from ten studies</mark>. No clinical benefit in children[<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>,<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>]"
        },
        {
            "participant": "children",
            "number": 600,
            "context": "No clinical benefit in children10,11. <mark class=\"stats\">No effect in largest randomised controlled trial of 600 children, of whom 305 (51%) had been treated with corticosteroids</mark>. CoV=coronavirus"
        },
        {
            "participant": "adults",
            "number": 309,
            "context": "Theoretically, corticosteroid treatment could have a role to suppress lung inflammation. <mark class=\"stats\">In a retrospective observational study reporting on 309 adults who were critically ill with MERS,[<a class=\"ref-link\" id=\"c2\" href=\"#r2\">2</a>] almost half of patients (151 [49%]) were given corticosteroids (median hydrocortisone equivalent dose [ie, methylprednisolone 1:5, dexamethasone 1:25, prednisolone 1:4] of 300 mg/day)</mark>. Patients who were given corticosteroids were more likely to require mechanical ventilation, vasopressors, and renal replacement therapy"
        },
        {
            "participant": "studies",
            "number": 4,
            "context": "However, these effect estimates have a high risk of error due to the probable presence of unmeasured confounders. <mark class=\"stats\">In a meta-analysis of corticosteroid use in patients with SARS, only four studies provided conclusive data, all indicating harm.1</mark>. The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).[<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>]"
        },
        {
            "participant": "data",
            "number": 15,
            "context": "In a meta-analysis of corticosteroid use in patients with SARS, only four studies provided conclusive data, all indicating harm.1. <mark class=\"stats\">The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).6</mark>. The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone (mean 4\u00b78 days [95% CI 4\u00b71\u20135\u00b75] since fever onset) had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]"
        },
        {
            "participant": "patients",
            "number": 9,
            "context": "The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).6. <mark class=\"stats\">The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone (mean 4\u00b78 days [95% CI 4\u00b71\u20135\u00b75] since fever onset) had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.5</mark>. The remaining two studies reported diabetes and avascular necrosis as complications associated with corticosteroid treatment.[<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>]"
        },
        {
            "participant": "studies",
            "number": 2,
            "context": "The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone (mean 4\u00b78 days [95% CI 4\u00b71\u20135\u00b75] since fever onset) had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.5. <mark class=\"stats\">The remaining two studies reported diabetes and avascular necrosis as complications associated with corticosteroid treatment.7,8</mark>. A 2019 systematic review and meta-analysis[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] iden\u00ad tified ten observational studies in influenza, with a total of 6548 patients"
        },
        {
            "participant": "observational studies",
            "number": 10,
            "context": "The remaining two studies reported diabetes and avascular necrosis as complications associated with corticosteroid treatment.7,8. <mark class=\"stats\">A 2019 systematic review and meta-analysis[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] iden\u00ad tified ten observational studies in influenza, with a total of 6548 patients</mark>. The investigators found increased mortality in patients who were given corticosteroids (risk ratio [RR] 1\u00b775, 95% CI 1\u00b73\u20132\u00b74; p=0\u00b70002)"
        },
        {
            "participant": "adults with RSV infection",
            "number": 50,
            "context": "Corticosteroids have been investigated for respiratory syncytial virus (RSV) in clinical trials in children, with no conclusive evidence of benefit and are therefore not recommended.10. <mark class=\"stats\">An observational study of 50 adults with RSV infection, in which 33 (66%) were given www.thelancet.com Vol 395 February 15, 2020</mark>. corticosteroids, suggested impaired antibody responses at 28 days in those given corticosteroids.[<a class=\"ref-link\" id=\"c17\" href=\"#r17\">17</a>]"
        },
        {
            "participant": "studies with a total of 574 patients",
            "number": 6,
            "context": "However, generalising evidence from acute respiratory distress syndrome studies to viral lung injury is problematic because these trials typically include a majority of patients with acute respiratory distress syndrome of non-pulmonary or sterile cause. <mark class=\"stats\">A review of treatments for acute respiratory distress syndrome of any cause, based on six studies with a total of 574 patients,[<a class=\"ref-link\" id=\"c19\" href=\"#r19\">19</a>] concluded that insufficient evidence exists to recommend corticosteroid treatment.20</mark>. Septic shock has been reported in seven (5%) of 140 patients with 2019-nCoV included in published reports as of Jan 29, 2020.3,18 Corticosteroids are widely used in septic shock despite uncertainty over their efficacy"
        },
        {
            "participant": "patients with 2019-nCoV included in published reports as",
            "number": 140,
            "context": "A review of treatments for acute respiratory distress syndrome of any cause, based on six studies with a total of 574 patients,[<a class=\"ref-link\" id=\"c19\" href=\"#r19\">19</a>] concluded that insufficient evidence exists to recommend corticosteroid treatment.20. <mark class=\"stats\">Septic shock has been reported in seven (5%) of 140 patients with 2019-nCoV included in published reports as of Jan 29, 2020.3,18 Corticosteroids are widely used in septic shock despite uncertainty over their efficacy</mark>. Most patients in septic shock trials have bacterial infection, leading to vasoplegic shock and myocardial insufficiency.[<a class=\"ref-link\" id=\"c21\" href=\"#r21\">21</a>,<a class=\"ref-link\" id=\"c22\" href=\"#r22\">22</a>]"
        }
    ],
    "statistics": [
        {
            "p_value": "p=0.12",
            "context": "Patients who were given corticosteroids were more likely to require mechanical ventilation, vasopressors, and renal replacement therapy. <mark class=\"stats\">After statistical adjustment for immortal time and indication biases, the authors concluded that administration of corticosteroids was not associated with a difference in 90-day mortality (adjusted odds ratio 0\u00b78, 95% CI 0\u00b75\u20131\u00b71; p=0\u00b712) but was associated with delayed clearance of viral RNA from respiratory tract secretions (adjusted hazard ratio 0\u00b74, 95% CI 0\u00b72\u20130\u00b77; p=0\u00b70005)</mark>. However, these effect estimates have a high risk of error due to the probable presence of unmeasured confounders",
            "tests": {
                "tests": [
                    {
                        "test": "odds ratio",
                        "value": "0\u00b78"
                    }
                ]
            }
        },
        {
            "p_value": "p=0.017",
            "context": "In a meta-analysis of corticosteroid use in patients with SARS, only four studies provided conclusive data, all indicating harm.1. <mark class=\"stats\">The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).6</mark>. The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone (mean 4\u00b78 days [95% CI 4\u00b71\u20135\u00b75] since fever onset) had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.5"
        },
        {
            "p_value": "p=0.0002",
            "context": "A 2019 systematic review and meta-analysis9 iden\u00ad tified ten observational studies in influenza, with a total of 6548 patients. <mark class=\"stats\">The investigators found increased mortality in patients who were given corticosteroids (risk ratio [RR] 1\u00b775, 95% CI 1\u00b73\u20132\u00b74; p=0\u00b70002)</mark>. Among other outcomes, length of stay in an intensive care unit was increased (mean difference 2\u00b71, 95% CI 1\u00b72\u20133\u00b71; p<0\u00b70001), as was the rate of secondary bacterial or fungal infection (RR 2\u00b70, 95% CI 1\u00b70\u20133\u00b78; p=0\u00b704)"
        },
        {
            "p_value": "p<0.0001",
            "context": "The investigators found increased mortality in patients who were given corticosteroids (risk ratio [RR] 1\u00b775, 95% CI 1\u00b73\u20132\u00b74; p=0\u00b70002). <mark class=\"stats\">Among other outcomes, length of stay in an intensive care unit was increased (mean difference 2\u00b71, 95% CI 1\u00b72\u20133\u00b71; p<0\u00b70001), as was the rate of secondary bacterial or fungal infection (RR 2\u00b70, 95% CI 1\u00b70\u20133\u00b78; p=0\u00b704)</mark>. Corticosteroids have been investigated for respiratory syncytial virus (RSV) in clinical trials in children, with no conclusive evidence of benefit and are therefore not recommended.10"
        }
    ],
    "keywords": [
        "clinical feature",
        "disease control",
        "severe acute respiratory syndrome",
        "novel coronavirus pneumonia",
        "influenza pandemic",
        "epidemiology",
        "coronavirus pneumonia",
        "sex specific mortality",
        "infect dis",
        "Viral disease",
        "us centers",
        "descriptive study",
        "corticosteroid treatment",
        "saudi arabia",
        "east respiratory syndrome coronavirus",
        "syndrome coronavirus disease",
        "novel coronavirus",
        "arabia",
        "pneumonia",
        "middle east respiratory syndrome",
        "clinical characteristics",
        "respiratory syncytial virus"
    ],
    "keyword_relevance": {
        "severe acute respiratory syndrome": 0.2980769230769231,
        "novel coronavirus": 0.27884615384615385,
        "corticosteroid treatment": 0.07692307692307693,
        "respiratory syncytial virus": 0.07692307692307693,
        "Middle East respiratory syndrome": 0.07692307692307693,
        "pneumonia": 0.057692307692307696,
        "novel coronavirus pneumonia": 0.028846153846153848,
        "coronavirus pneumonia": 0.028846153846153848,
        "descriptive study": 0.019230769230769232,
        "clinical characteristics": 0.019230769230769232,
        "influenza pandemic": 0.009615384615384616,
        "epidemiology": 0.009615384615384616,
        "syndrome coronavirus disease": 0.009615384615384616,
        "middle east respiratory syndrome": 0.009615384615384616,
        "clinical feature": 0.0,
        "disease control": 0.0,
        "sex specific mortality": 0.0,
        "infect dis": 0.0,
        "Viral disease": 0.0,
        "us centers": 0.0,
        "saudi arabia": 0.0,
        "east respiratory syndrome coronavirus": 0.0,
        "arabia": 0.0
    },
    "species": [],
    "summary": [
        "11 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.",
        "Https://www.who.int/news-room/detail/23-01-2020-statement-on-themeeting-of-the-international-health-regulations-(2005)-emergencycommittee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).",
        "Https://www.who.int/internal-publications-detail/ clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus--infection-is-suspected.",
        "Corticosteroids were widely used during the outbreaks of severe acute respiratory syndrome (SARS)-CoV1 and",
        "Middle East respiratory syndrome (MERS)-CoV,[<a class=\"ref-link\" id=\"c2\" href=\"#r2\">2</a>] and are being used in patients with 2019-nCoV in addition to other therapeutics.[<a class=\"ref-link\" id=\"c3\" href=\"#r3\">3</a>] current interim guidance from WHO on clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected advises against the use of corticosteroids unless indicated for",
        "In SARS-CoV infection, as with influenza, systemic inflammation is associated with adverse outcomes.[<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] In SARS, inflammation persists after viral clearance.[<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>,<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>] Pulmonary histology in both SARS and MERS infections reveals inflammation and diffuse alveolar damage,[<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>] with one report suggesting haemophagocytosis.[<a class=\"ref-link\" id=\"c16\" href=\"#r16\">16</a>] Theoretically, corticosteroid treatment could have a role to suppress lung inflammation.",
        "In a meta-analysis of corticosteroid use in patients with SARS, only four studies provided conclusive data, all indicating harm.[<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>] The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).[<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>] The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>] The remaining two studies reported diabetes and avascular necrosis as complications associated with corticosteroid treatment.[<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>]",
        "Corticosteroids have been investigated for respiratory syncytial virus (RSV) in clinical trials in children, with no conclusive evidence of benefit and are not recommended.[<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>] An observational study of 50 adults with RSV infection, in which 33 (66%) were given www.thelancet.com Vol 395 February 15, 2020",
        "A review of treatments for acute respiratory distress syndrome of any cause, based on six studies with a total of 574 patients,[<a class=\"ref-link\" id=\"c19\" href=\"#r19\">19</a>] concluded that insufficient evidence exists to recommend corticosteroid treatment.[<a class=\"ref-link\" id=\"c20\" href=\"#r20\">20</a>]",
        "No clinical data exist to indicate that net benefit is derived from corticosteroids in the treatment of respiratory infection due to RSV, influenza, SARS-CoV, or MERS-CoV.",
        "The available observational data suggest increased mortality and secondary infection rates in influenza, impaired clearance of SARS-CoV and MERS-CoV, and complications of corticosteroid therapy in survivors.",
        "Clinical management of severe acute respiratory infection when novel coronavirus infection is suspected.",
        "Https://www.who.int/publications-detail/ clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus--infection-is-suspected."
    ],
    "structured_summary": {
        "Introduction": [
            "11 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.",
            "Https://www.who.int/news-room/detail/23-01-2020-statement-on-themeeting-of-the-international-health-regulations-(2005)-emergencycommittee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).",
            "Https://www.who.int/internal-publications-detail/ clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus--infection-is-suspected."
        ],
        "Results": [
            "Corticosteroids were widely used during the outbreaks of severe acute respiratory syndrome (SARS)-CoV1 and",
            "Middle East respiratory syndrome (MERS)-CoV,[<a class=\"ref-link\" id=\"c2\" href=\"#r2\">2</a>] and are being used in patients with 2019-nCoV in addition to other therapeutics.[<a class=\"ref-link\" id=\"c3\" href=\"#r3\">3</a>] current interim guidance from WHO on clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected advises against the use of corticosteroids unless indicated for",
            "In SARS-CoV infection, as with influenza, systemic inflammation is associated with adverse outcomes.[<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] In SARS, inflammation persists after viral clearance.[<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>,<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>] Pulmonary histology in both SARS and MERS infections reveals inflammation and diffuse alveolar damage,[<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>] with one report suggesting haemophagocytosis.[<a class=\"ref-link\" id=\"c16\" href=\"#r16\">16</a>] Theoretically, corticosteroid treatment could have a role to suppress lung inflammation.",
            "In a meta-analysis of corticosteroid use in patients with SARS, only four studies provided conclusive data, all indicating harm.[<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>] The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).[<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>] The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>] The remaining two studies reported diabetes and avascular necrosis as complications associated with corticosteroid treatment.[<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>,<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>]",
            "Corticosteroids have been investigated for respiratory syncytial virus (RSV) in clinical trials in children, with no conclusive evidence of benefit and are not recommended.[<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>] An observational study of 50 adults with RSV infection, in which 33 (66%) were given www.thelancet.com Vol 395 February 15, 2020",
            "A review of treatments for acute respiratory distress syndrome of any cause, based on six studies with a total of 574 patients,[<a class=\"ref-link\" id=\"c19\" href=\"#r19\">19</a>] concluded that insufficient evidence exists to recommend corticosteroid treatment.[<a class=\"ref-link\" id=\"c20\" href=\"#r20\">20</a>]",
            "No clinical data exist to indicate that net benefit is derived from corticosteroids in the treatment of respiratory infection due to RSV, influenza, SARS-CoV, or MERS-CoV."
        ],
        "Conclusion": [
            "The available observational data suggest increased mortality and secondary infection rates in influenza, impaired clearance of SARS-CoV and MERS-CoV, and complications of corticosteroid therapy in survivors.",
            "Clinical management of severe acute respiratory infection when novel coronavirus infection is suspected.",
            "Https://www.who.int/publications-detail/ clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus--infection-is-suspected."
        ]
    },
    "reference_links": [
        {
            "id": "3",
            "alt_id": "3_2020_a",
            "entry": "3 China National Health Commission. Update on the novel coronavirus pneumonia outbreak (Jan 24, 2020). Beijing: China National Health Commission, 2020. http://www.nhc.gov.cn/xcs/yqfkdt/202001/c5da49c4c5bf4bcfb320ec2036480627.shtml (accessed Jan 24, 2020).",
            "url": "http://www.nhc.gov.cn/xcs/yqfkdt/202001/c5da49c4c5bf4bcfb320ec2036480627.shtml"
        },
        {
            "id": "5",
            "alt_id": "5_2019_a",
            "entry": "5 US Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States. Atlanta, GA: US Centers for Disease Control and Prevention, 2020. https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html (accessed Jan 24, 2020).",
            "url": "https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html"
        },
        {
            "id": "6",
            "alt_id": "Chan_et+al_Jan_a",
            "entry": "6 Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; published online Jan 24. https://doi.org/10.1016/S0140-6736(20)30154-9.",
            "crossref": "https://dx.doi.org/10.1016/S0140-6736(20)30154-9",
            "scite": "https://scite.ai/reports/10.1016/S0140-6736(20)30154-9",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1016/S0140-6736%2820%2930154-9"
        },
        {
            "id": "7",
            "alt_id": "Huang_et+al_Jan_a",
            "entry": "7 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; published online Jan 24. https://doi.org/10.1016/S0140-6736(20)30183-5.",
            "crossref": "https://dx.doi.org/10.1016/S0140-6736(20)30183-5",
            "scite": "https://scite.ai/reports/10.1016/S0140-6736(20)30183-5",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1016/S0140-6736%2820%2930183-5"
        },
        {
            "id": "8",
            "alt_id": "Leung_et+al_2004_a",
            "entry": "8 Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 2004; 141: 662\u201373.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Leung%20GM%20Hedley%20AJ%20Ho%20LM%20et%20al%20The%20epidemiology%20of%20severe%20acute%20respiratory%20syndrome%20in%20the%202003%20Hong%20Kong%20epidemic%20an%20analysis%20of%20all%201755%20patients%20Ann%20Intern%20Med%202004%20141%2066273",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Leung%20GM%20Hedley%20AJ%20Ho%20LM%20et%20al%20The%20epidemiology%20of%20severe%20acute%20respiratory%20syndrome%20in%20the%202003%20Hong%20Kong%20epidemic%20an%20analysis%20of%20all%201755%20patients%20Ann%20Intern%20Med%202004%20141%2066273",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Leung%20GM%20Hedley%20AJ%20Ho%20LM%20et%20al%20The%20epidemiology%20of%20severe%20acute%20respiratory%20syndrome%20in%20the%202003%20Hong%20Kong%20epidemic%20an%20analysis%20of%20all%201755%20patients%20Ann%20Intern%20Med%202004%20141%2066273"
        },
        {
            "id": "11",
            "alt_id": "Assiri_et+al_2013_a",
            "entry": "11 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752\u201361.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Assiri%2C%20A.%20Al-Tawfiq%2C%20J.A.%20Al-Rabeeah%2C%20A.A.%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia%3A%20a%20descriptive%20study%202013",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Assiri%2C%20A.%20Al-Tawfiq%2C%20J.A.%20Al-Rabeeah%2C%20A.A.%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia%3A%20a%20descriptive%20study%202013",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Assiri%2C%20A.%20Al-Tawfiq%2C%20J.A.%20Al-Rabeeah%2C%20A.A.%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia%3A%20a%20descriptive%20study%202013"
        },
        {
            "id": "13",
            "alt_id": "Viboud_et+al_2013_a",
            "entry": "13 Viboud C, Eisenstein J, Reid AH, Janczewski TA, Morens DM, Taubenberger JK. Age- and sex-specific mortality associated with the 1918\u20131919 influenza pandemic in Kentucky. J Infect Dis 2013; 207: 721\u201329.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Viboud%20C%20Eisenstein%20J%20Reid%20AH%20Janczewski%20TA%20Morens%20DM%20Taubenberger%20JK%20Age%20and%20sexspecific%20mortality%20associated%20with%20the%2019181919%20influenza%20pandemic%20in%20Kentucky%20J%20Infect%20Dis%202013%20207%2072129",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Viboud%20C%20Eisenstein%20J%20Reid%20AH%20Janczewski%20TA%20Morens%20DM%20Taubenberger%20JK%20Age%20and%20sexspecific%20mortality%20associated%20with%20the%2019181919%20influenza%20pandemic%20in%20Kentucky%20J%20Infect%20Dis%202013%20207%2072129",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Viboud%20C%20Eisenstein%20J%20Reid%20AH%20Janczewski%20TA%20Morens%20DM%20Taubenberger%20JK%20Age%20and%20sexspecific%20mortality%20associated%20with%20the%2019181919%20influenza%20pandemic%20in%20Kentucky%20J%20Infect%20Dis%202013%20207%2072129"
        },
        {
            "id": "14",
            "alt_id": "Zhong_et+al_2003_a",
            "entry": "14 Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet 2003; 362: 1353\u201358.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhong%2C%20N.S.%20Zheng%2C%20B.J.%20Li%2C%20Y.M.%20Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zhong%2C%20N.S.%20Zheng%2C%20B.J.%20Li%2C%20Y.M.%20Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zhong%2C%20N.S.%20Zheng%2C%20B.J.%20Li%2C%20Y.M.%20Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%202003"
        },
        {
            "id": "16",
            "alt_id": "16_2020_b",
            "entry": "16 Announcement from the Headquarter for novel coronavirus pneumonia prevention and control (No. 1). Beijing: China National Health Commission, 2020. http://www.gov.cn/xinwen/2020-01/23/content_5471751.htm (accessed Jan 23, 2020).",
            "url": "http://www.gov.cn/xinwen/2020-01/23/content_5471751.htm"
        },
        {
            "id": "1",
            "alt_id": "Stockman_et+al_2006_a",
            "entry": "1 Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006; 3: e343.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Stockman%2C%20L.J.%20Bellamy%2C%20R.%20Garner%2C%20P.%20SARS%3A%20systematic%20review%20of%20treatment%20effects%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Stockman%2C%20L.J.%20Bellamy%2C%20R.%20Garner%2C%20P.%20SARS%3A%20systematic%20review%20of%20treatment%20effects%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Stockman%2C%20L.J.%20Bellamy%2C%20R.%20Garner%2C%20P.%20SARS%3A%20systematic%20review%20of%20treatment%20effects%202006"
        },
        {
            "id": "2",
            "alt_id": "Arabi_et+al_2018_a",
            "entry": "2 Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 2018; 197: 757\u201367.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Arabi%2C%20Y.M.%20Mandourah%2C%20Y.%20Al-Hameed%2C%20F.%20Corticosteroid%20therapy%20for%20critically%20ill%20patients%20with%20middle%20east%20respiratory%20syndrome%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Arabi%2C%20Y.M.%20Mandourah%2C%20Y.%20Al-Hameed%2C%20F.%20Corticosteroid%20therapy%20for%20critically%20ill%20patients%20with%20middle%20east%20respiratory%20syndrome%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Arabi%2C%20Y.M.%20Mandourah%2C%20Y.%20Al-Hameed%2C%20F.%20Corticosteroid%20therapy%20for%20critically%20ill%20patients%20with%20middle%20east%20respiratory%20syndrome%202018"
        },
        {
            "id": "3",
            "alt_id": "Huang_et+al_Jan_b",
            "entry": "3 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; published online Jan 24. https://doi.org/10.1016/S0140-6736(20)30183-5.",
            "crossref": "https://dx.doi.org/10.1016/S0140-6736(20)30183-5",
            "scite": "https://scite.ai/reports/10.1016/S0140-6736(20)30183-5",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1016/S0140-6736%2820%2930183-5"
        },
        {
            "id": "5",
            "alt_id": "Lee_et+al_2004_a",
            "entry": "5 Lee N, Allen Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol 2004; 31: 304\u201309.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lee%2C%20N.%20Allen%20Chan%2C%20K.C.%20Hui%2C%20D.S.%20Effects%20of%20early%20corticosteroid%20treatment%20on%20plasma%20SARS-associated%20Coronavirus%20RNA%20concentrations%20in%20adult%20patients%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lee%2C%20N.%20Allen%20Chan%2C%20K.C.%20Hui%2C%20D.S.%20Effects%20of%20early%20corticosteroid%20treatment%20on%20plasma%20SARS-associated%20Coronavirus%20RNA%20concentrations%20in%20adult%20patients%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lee%2C%20N.%20Allen%20Chan%2C%20K.C.%20Hui%2C%20D.S.%20Effects%20of%20early%20corticosteroid%20treatment%20on%20plasma%20SARS-associated%20Coronavirus%20RNA%20concentrations%20in%20adult%20patients%202004"
        },
        {
            "id": "6",
            "alt_id": "Lee_et+al_2004_b",
            "entry": "6 Lee DTS, Wing YK, Leung HCM, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis 2004; 39: 1247\u201349.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lee%2C%20D.T.S.%20Wing%2C%20Y.K.%20Leung%2C%20H.C.M.%20Factors%20associated%20with%20psychosis%20among%20patients%20with%20severe%20acute%20respiratory%20syndrome%3A%20a%20case-control%20study%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lee%2C%20D.T.S.%20Wing%2C%20Y.K.%20Leung%2C%20H.C.M.%20Factors%20associated%20with%20psychosis%20among%20patients%20with%20severe%20acute%20respiratory%20syndrome%3A%20a%20case-control%20study%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lee%2C%20D.T.S.%20Wing%2C%20Y.K.%20Leung%2C%20H.C.M.%20Factors%20associated%20with%20psychosis%20among%20patients%20with%20severe%20acute%20respiratory%20syndrome%3A%20a%20case-control%20study%202004"
        },
        {
            "id": "7",
            "alt_id": "Xiao_et+al_2004_a",
            "entry": "7 Xiao JZ, Ma L, Gao J, et al. Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Nei Ke Za Zhi 2004; 43: 179\u201382 (in Chinese).",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Xiao%2C%20J.Z.%20Ma%2C%20L.%20Gao%2C%20J.%20Glucocorticoid-induced%20diabetes%20in%20severe%20acute%20respiratory%20syndrome%3A%20the%20impact%20of%20high%20dosage%20and%20duration%20of%20methylprednisolone%20therapy.%20Zhonghua%20Nei%20Ke%20Za%20Zhi%202004"
        },
        {
            "id": "8",
            "alt_id": "Li_et+al_2004_a",
            "entry": "8 Li YM, Wang SX, Gao HS, et al. Factors of avascular necrosis of femoral head and osteoporosis in SARS patients\u2019 convalescence. Zhonghua Yi Xue Za Zhi 2004; 84: 1348\u201353 (in Chinese).",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Li%2C%20Y.M.%20Wang%2C%20S.X.%20Gao%2C%20H.S.%20Factors%20of%20avascular%20necrosis%20of%20femoral%20head%20and%20osteoporosis%20in%20SARS%20patients%E2%80%99%20convalescence.%20Zhonghua%20Yi%20Xue%20Za%20Zhi%202004"
        },
        {
            "id": "9",
            "alt_id": "Ni_et+al_2019_a",
            "entry": "9 Ni Y-N, Chen G, Sun J, Liang B-M, Liang Z-A. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care 2019; 23: 99.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ni%2C%20Y.-N.%20Chen%2C%20G.%20Sun%2C%20J.%20Liang%2C%20B.-M.%20The%20effect%20of%20corticosteroids%20on%20mortality%20of%20patients%20with%20influenza%20pneumonia%3A%20a%20systematic%20review%20and%20meta-analysis%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ni%2C%20Y.-N.%20Chen%2C%20G.%20Sun%2C%20J.%20Liang%2C%20B.-M.%20The%20effect%20of%20corticosteroids%20on%20mortality%20of%20patients%20with%20influenza%20pneumonia%3A%20a%20systematic%20review%20and%20meta-analysis%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ni%2C%20Y.-N.%20Chen%2C%20G.%20Sun%2C%20J.%20Liang%2C%20B.-M.%20The%20effect%20of%20corticosteroids%20on%20mortality%20of%20patients%20with%20influenza%20pneumonia%3A%20a%20systematic%20review%20and%20meta-analysis%202019"
        },
        {
            "id": "10",
            "alt_id": "Mcgee_2008_a",
            "entry": "10 McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008; 168: 1034\u201346.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=McGee%2C%20S.%20Hirschmann%2C%20J.%20Use%20of%20corticosteroids%20in%20treating%20infectious%20diseases%202008",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=McGee%2C%20S.%20Hirschmann%2C%20J.%20Use%20of%20corticosteroids%20in%20treating%20infectious%20diseases%202008",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=McGee%2C%20S.%20Hirschmann%2C%20J.%20Use%20of%20corticosteroids%20in%20treating%20infectious%20diseases%202008"
        },
        {
            "id": "11",
            "alt_id": "Corneli_et+al_2007_a",
            "entry": "11 Corneli HM, Zorc JJ, Mahajan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007; 357: 331\u201339.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Corneli%2C%20H.M.%20Zorc%2C%20J.J.%20Mahajan%2C%20P.%20A%20multicenter%2C%20randomized%2C%20controlled%20trial%20of%20dexamethasone%20for%20bronchiolitis%202007",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Corneli%2C%20H.M.%20Zorc%2C%20J.J.%20Mahajan%2C%20P.%20A%20multicenter%2C%20randomized%2C%20controlled%20trial%20of%20dexamethasone%20for%20bronchiolitis%202007",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Corneli%2C%20H.M.%20Zorc%2C%20J.J.%20Mahajan%2C%20P.%20A%20multicenter%2C%20randomized%2C%20controlled%20trial%20of%20dexamethasone%20for%20bronchiolitis%202007"
        },
        {
            "id": "12",
            "alt_id": "Tang_et+al_2005_a",
            "entry": "12 Tang NL-S, Chan PK-S, Wong C-K, et al. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem 2005; 51: 2333\u201340.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Tang%2C%20N.L.-S.%20Chan%2C%20P.K.-S.%20Wong%2C%20C.-K.%20Early%20enhanced%20expression%20of%20interferon-inducible%20protein-10%20%28CXCL-10%29%20and%20other%20chemokines%20predicts%20adverse%20outcome%20in%20severe%20acute%20respiratory%20syndrome%202005",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Tang%2C%20N.L.-S.%20Chan%2C%20P.K.-S.%20Wong%2C%20C.-K.%20Early%20enhanced%20expression%20of%20interferon-inducible%20protein-10%20%28CXCL-10%29%20and%20other%20chemokines%20predicts%20adverse%20outcome%20in%20severe%20acute%20respiratory%20syndrome%202005",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Tang%2C%20N.L.-S.%20Chan%2C%20P.K.-S.%20Wong%2C%20C.-K.%20Early%20enhanced%20expression%20of%20interferon-inducible%20protein-10%20%28CXCL-10%29%20and%20other%20chemokines%20predicts%20adverse%20outcome%20in%20severe%20acute%20respiratory%20syndrome%202005"
        },
        {
            "id": "13",
            "alt_id": "Peiris_et+al_2003_a",
            "entry": "13 Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767\u201372.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Peiris%2C%20J.S.M.%20Chu%2C%20C.M.%20Cheng%2C%20V.C.C.%20Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia%3A%20a%20prospective%20study%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Peiris%2C%20J.S.M.%20Chu%2C%20C.M.%20Cheng%2C%20V.C.C.%20Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia%3A%20a%20prospective%20study%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Peiris%2C%20J.S.M.%20Chu%2C%20C.M.%20Cheng%2C%20V.C.C.%20Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia%3A%20a%20prospective%20study%202003"
        },
        {
            "id": "14",
            "alt_id": "14_2003_a",
            "entry": "14 Beijing Group of National Research Project for SARS. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin Med J (Engl) 2003; 116: 1283\u201387.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Beijing%20Group%20of%20National%20Research%20Project%20for%20SARS%20Dynamic%20changes%20in%20blood%20cytokine%20levels%20as%20clinical%20indicators%20in%20severe%20acute%20respiratory%20syndrome%20Chin%20Med%20J%20Engl%202003%20116%20128387",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Beijing%20Group%20of%20National%20Research%20Project%20for%20SARS%20Dynamic%20changes%20in%20blood%20cytokine%20levels%20as%20clinical%20indicators%20in%20severe%20acute%20respiratory%20syndrome%20Chin%20Med%20J%20Engl%202003%20116%20128387",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Beijing%20Group%20of%20National%20Research%20Project%20for%20SARS%20Dynamic%20changes%20in%20blood%20cytokine%20levels%20as%20clinical%20indicators%20in%20severe%20acute%20respiratory%20syndrome%20Chin%20Med%20J%20Engl%202003%20116%20128387"
        },
        {
            "id": "15",
            "alt_id": "Arabi_et+al_2017_a",
            "entry": "15 Arabi YM, Balkhy HH, Hayden FG, et al. Middle East respiratory syndrome. N Engl J Med 2017; 376: 584\u201394.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Arabi%2C%20Y.M.%20Balkhy%2C%20H.H.%20Hayden%2C%20F.G.%20Middle%20East%20respiratory%20syndrome%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Arabi%2C%20Y.M.%20Balkhy%2C%20H.H.%20Hayden%2C%20F.G.%20Middle%20East%20respiratory%20syndrome%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Arabi%2C%20Y.M.%20Balkhy%2C%20H.H.%20Hayden%2C%20F.G.%20Middle%20East%20respiratory%20syndrome%202017"
        },
        {
            "id": "16",
            "alt_id": "Nicholls_et+al_2003_a",
            "entry": "16 Nicholls JM, Poon LLM, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361: 1773\u201378.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Nicholls%2C%20J.M.%20Poon%2C%20L.L.M.%20Lee%2C%20K.C.%20Lung%20pathology%20of%20fatal%20severe%20acute%20respiratory%20syndrome%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Nicholls%2C%20J.M.%20Poon%2C%20L.L.M.%20Lee%2C%20K.C.%20Lung%20pathology%20of%20fatal%20severe%20acute%20respiratory%20syndrome%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Nicholls%2C%20J.M.%20Poon%2C%20L.L.M.%20Lee%2C%20K.C.%20Lung%20pathology%20of%20fatal%20severe%20acute%20respiratory%20syndrome%202003"
        },
        {
            "id": "17",
            "alt_id": "Lee_et+al_2011_a",
            "entry": "17 Lee FE-H, Walsh EE, Falsey AR. The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness. Chest 2011; 140: 1155\u201361.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lee%2C%20F.E.-H.%20Walsh%2C%20E.E.%20Falsey%2C%20A.R.%20The%20effect%20of%20steroid%20use%20in%20hospitalized%20adults%20with%20respiratory%20syncytial%20virus-related%20illness%202011",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lee%2C%20F.E.-H.%20Walsh%2C%20E.E.%20Falsey%2C%20A.R.%20The%20effect%20of%20steroid%20use%20in%20hospitalized%20adults%20with%20respiratory%20syncytial%20virus-related%20illness%202011",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lee%2C%20F.E.-H.%20Walsh%2C%20E.E.%20Falsey%2C%20A.R.%20The%20effect%20of%20steroid%20use%20in%20hospitalized%20adults%20with%20respiratory%20syncytial%20virus-related%20illness%202011"
        },
        {
            "id": "18",
            "alt_id": "Chen_et+al_Jan_a",
            "entry": "18 Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; published online Jan 30. https://doi.org/10.1016/S0140-6736(20)30211-7.",
            "crossref": "https://dx.doi.org/10.1016/S0140-6736(20)30211-7",
            "scite": "https://scite.ai/reports/10.1016/S0140-6736(20)30211-7",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1016/S0140-6736%2820%2930211-7"
        },
        {
            "id": "19",
            "alt_id": "Ashbaugh_et+al_1967_a",
            "entry": "19 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319\u201323.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ashbaugh%2C%20D.G.%20Bigelow%2C%20D.B.%20Petty%2C%20T.L.%20Levine%2C%20B.E.%20Acute%20respiratory%20distress%20in%20adults%201967",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ashbaugh%2C%20D.G.%20Bigelow%2C%20D.B.%20Petty%2C%20T.L.%20Levine%2C%20B.E.%20Acute%20respiratory%20distress%20in%20adults%201967",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ashbaugh%2C%20D.G.%20Bigelow%2C%20D.B.%20Petty%2C%20T.L.%20Levine%2C%20B.E.%20Acute%20respiratory%20distress%20in%20adults%201967"
        },
        {
            "id": "20",
            "alt_id": "Lewis_et+al_2019_a",
            "entry": "20 Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev 2019; 7: CD004477.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lewis%2C%20SR%2C%20Pritchard%20MW%2C%20Thomas%20CM%2C%20Smith%20A.F.%20Pharmacological%20agents%20for%20adults%20with%20acute%20respiratory%20distress%20syndrome%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lewis%2C%20SR%2C%20Pritchard%20MW%2C%20Thomas%20CM%2C%20Smith%20A.F.%20Pharmacological%20agents%20for%20adults%20with%20acute%20respiratory%20distress%20syndrome%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lewis%2C%20SR%2C%20Pritchard%20MW%2C%20Thomas%20CM%2C%20Smith%20A.F.%20Pharmacological%20agents%20for%20adults%20with%20acute%20respiratory%20distress%20syndrome%202019"
        },
        {
            "id": "21",
            "alt_id": "Venkatesh_et+al_2018_a",
            "entry": "21 Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018; 378: 797\u2013808.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Venkatesh%2C%20B.%20Finfer%2C%20S.%20Cohen%2C%20J.%20Adjunctive%20glucocorticoid%20therapy%20in%20patients%20with%20septic%20shock%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Venkatesh%2C%20B.%20Finfer%2C%20S.%20Cohen%2C%20J.%20Adjunctive%20glucocorticoid%20therapy%20in%20patients%20with%20septic%20shock%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Venkatesh%2C%20B.%20Finfer%2C%20S.%20Cohen%2C%20J.%20Adjunctive%20glucocorticoid%20therapy%20in%20patients%20with%20septic%20shock%202018"
        },
        {
            "id": "22",
            "alt_id": "Annane_et+al_2018_a",
            "entry": "22 Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 2018; 378: 809\u201318.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Annane%2C%20D.%20Renault%2C%20A.%20Brun-Buisson%2C%20C.%20Hydrocortisone%20plus%20fludrocortisone%20for%20adults%20with%20septic%20shock%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Annane%2C%20D.%20Renault%2C%20A.%20Brun-Buisson%2C%20C.%20Hydrocortisone%20plus%20fludrocortisone%20for%20adults%20with%20septic%20shock%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Annane%2C%20D.%20Renault%2C%20A.%20Brun-Buisson%2C%20C.%20Hydrocortisone%20plus%20fludrocortisone%20for%20adults%20with%20septic%20shock%202018"
        },
        {
            "id": "23",
            "alt_id": "Foug\u00e8res_et+al_2010_a",
            "entry": "23 Foug\u00e8res E, Teboul J-L, Richard C, Osman D, Chemla D, Monnet X. Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status. Crit Care Med 2010; 38: 802\u201307.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Foug%C3%A8res%2C%20E.%20Teboul%2C%20J.-L.%20Richard%2C%20C.%20Osman%2C%20D.%20Hemodynamic%20impact%20of%20a%20positive%20end-expiratory%20pressure%20setting%20in%20acute%20respiratory%20distress%20syndrome%3A%20importance%20of%20the%20volume%20status%202010",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Foug%C3%A8res%2C%20E.%20Teboul%2C%20J.-L.%20Richard%2C%20C.%20Osman%2C%20D.%20Hemodynamic%20impact%20of%20a%20positive%20end-expiratory%20pressure%20setting%20in%20acute%20respiratory%20distress%20syndrome%3A%20importance%20of%20the%20volume%20status%202010",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Foug%C3%A8res%2C%20E.%20Teboul%2C%20J.-L.%20Richard%2C%20C.%20Osman%2C%20D.%20Hemodynamic%20impact%20of%20a%20positive%20end-expiratory%20pressure%20setting%20in%20acute%20respiratory%20distress%20syndrome%3A%20importance%20of%20the%20volume%20status%202010"
        }
    ],
    "facts": [
        "sex-specific mortality associated with the 1918\u20131919 influenza pandemic in Kentucky",
        "Corticosteroids were widely used during the outbreaks of severe acute respiratory syndrome-CoV1",
        "inflammation persists after viral clearance.[13,14",
        "avascular necrosis as complications associated with corticosteroid treatment.[7,8",
        "Corticosteroids have been investigated for respiratory syncytial virus in clinical trials",
        "No clinical data exist to indicate that net benefit is derived from corticosteroids"
    ],
    "claims": [],
    "findings": [
        "Risk ratio for mortality 1\u00b775 (95% CI 1\u00b73\u20132\u00b74) in a meta-analysis of 6548 patients from ten studies",
        "After statistical adjustment for immortal time and indication biases, the authors concluded that administration of corticosteroids was not associated with a difference in 90-day mortality (adjusted odds ratio 0\u00b78, 95% CI 0\u00b75\u20131\u00b71; p=0\u00b712) but was associated with delayed clearance of viral RNA from respiratory tract secretions (adjusted hazard ratio 0\u00b74, 95% CI 0\u00b72\u20130\u00b77; p=0\u00b70005)",
        "The first was a case-control study of SARS patients with (n=15) and without (n=30) SARS-related psychosis; all were given corticosteroid treatment, but those who developed psychosis were given a higher cumulative dose than those who did not (10 975 mg hydrocortisone equivalent vs 6780 mg; p=0\u00b7017).[<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>]",
        "The second was a randomised controlled trial of 16 patients with SARS who were not critically ill; the nine patients who were given hydrocortisone (mean 4\u00b78 days [95% CI 4\u00b71\u20135\u00b75] since fever onset) had greater viraemia in the second and third weeks after infection than those who were given 0\u00b79% saline control.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]",
        "The investigators found increased mortality in patients who were given corticosteroids (risk ratio [RR] 1\u00b775, 95% CI 1\u00b73\u20132\u00b74; p=0\u00b70002)",
        "Among other outcomes, length of stay in an intensive care unit was increased (mean difference 2\u00b71, 95% CI 1\u00b72\u20133\u00b71; p<0\u00b70001), as was the rate of secondary bacterial or fungal infection (RR 2\u00b70, 95% CI 1\u00b70\u20133\u00b78; p=0\u00b704)"
    ],
    "processes": [],
    "key_statements": [
        "After statistical adjustment for immortal time and indication biases, the authors concluded that administration of corticosteroids was not associated with a difference in 90-day mortality but was associated with delayed clearance of viral RNA from respiratory tract secretions",
        "Length of stay in an intensive care unit was increased, as was the rate of secondary bacterial or fungal infection (RR 2\u00b70, 95% CI 1\u00b70\u20133\u00b78; p=0\u00b704)",
        "No clinical data exist to indicate that net benefit is derived from corticosteroids in the treatment of respiratory infection due to respiratory syncytial virus, influenza, severe acute respiratory syndrome-CoV, or Middle East respiratory syndrome-CoV"
    ],
    "top_statements": [
        "11 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study",
        "After statistical adjustment for immortal time and indication biases, the authors concluded that administration of corticosteroids was not associated with a difference in 90-day mortality but was associated with delayed clearance of viral RNA from respiratory tract secretions",
        "Length of stay in an intensive care unit was increased, as was the rate of secondary bacterial or fungal infection (RR 2\u00b70, 95% CI 1\u00b70\u20133\u00b78; p=0\u00b704)",
        "No clinical data exist to indicate that net benefit is derived from corticosteroids in the treatment of respiratory infection due to respiratory syncytial virus, influenza, severe acute respiratory syndrome-CoV, or Middle East respiratory syndrome-CoV"
    ],
    "headline": "No clinical data exist to indicate that net benefit is derived from corticosteroids in the treatment of respiratory infection due to respiratory syncytial virus, influenza, severe acute respiratory syndrome-CoV, or Middle East respiratory syndrome-CoV",
    "contexts": [],
    "abbreviations": {
        "nCoV": "novel coronavirus",
        "SARS": "severe acute respiratory syndrome",
        "MERS": "Middle East respiratory syndrome",
        "RSV": "respiratory syncytial virus"
    }
}
